GLG Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,754
Closed -$94K 355
2017
Q1
$94K Buy
+20,754
New +$94K ﹤0.01% 403